RLAY - Company ID 0001812364
The table below shows Relay Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $84.02M | $124.29M | $143.74M | $151.79M | $280.12M | $447.65M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | $306.00K | $306.00K | $403.00K | $75.00M |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $578.28M |
| $809.20M |
| $770.10M |
| $1.02B |
| $976.24M |
| $770.10M |
| Property, plant & equipment | $1.73M | $5.91M | $10.90M | $11.63M | $6.54M | $6.25M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $621.33M | $871.30M | $843.98M | $1.10B | $1.01B | $799.83M |
| Accounts payable | $7.71M | $14.10M | $9.21M | $10.58M | $8.28M | $6.35M |
| Total current liabilities | $25.58M | $50.73M | $30.27M | $63.71M | $24.32M | $13.63M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $54.27M | $93.50M | $91.98M | $149.55M | $110.64M | $36.54M |
| Retained earnings | -$2.01B | -$1.74B | -$1.40B | -$1.06B | -$768.10M | -$404.23M |
| Total equity | $567.06M | $777.79M | $752.00M | $950.22M | $897.81M | $763.29M |